Clinical Trial

Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer

Not Yet Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
Efficacy Study of Digoxin Combined with Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-10.
Trial Details
NCT Number NCT07025850
Lead Sponsor Fudan University
Collaborators: Anyang Tumor Hospital
Conditions Colorectal Carcinoma
Enrollment 20 participants
Start Date 2025-08-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-01